Procept Biorobotics

About Procept Biorobotics

Procept Biorobotics is a medical technology company specializing in the development and commercialization of innovative robotic systems for minimally invasive surgery. Operating at the intersection of robotics and healthcare, the company was founded with the mission to advance surgical precision and patient outcomes. While the exact founding date and location are not specified, the company's name suggests a focus on procedural innovation ("Procept") and biologically inspired robotics, positioning it as a leader in the evolving field of surgical automation. The company's flagship product is the AquaBeam Robotic System, a groundbreaking technology designed for the treatment of benign prostatic hyperplasia (BPH). This system utilizes a fully automated, waterjet-based approach to precisely remove excess prostate tissue, offering surgeons enhanced accuracy and reduced procedural variability. Key features include real-time imaging, autonomous tissue ablation, and minimal invasiveness, making it particularly suitable for urologists and patients seeking advanced, less disruptive treatment options. Procept Biorobotics targets urological surgeons and healthcare facilities aiming to improve procedural efficiency and patient recovery times. Procept Biorobotics has established itself as a pioneer in robotic-assisted surgery for BPH, differentiating itself through its unique waterjet technology and fully automated workflow. The company's commitment to innovation is reflected in its regulatory approvals and growing adoption in leading medical centers. By combining robotic precision with minimally invasive techniques, Procept Biorobotics delivers a unique value proposition that enhances surgical outcomes while reducing complications, solidifying its position as a key player in the medical robotics industry.